Sango-an, Jezzel B.

HRN: 27-49-66  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2026
CEFUROXIME 1.5GM (VIAL)
08/09/2026
08/15/2026
IV
1.5g
Q8
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: